Clinical trials
Hormones clinical trials
Below are recruiting hormones clinical trials, each written for real people, not researchers. We’re tracking 423 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07686718Recruiting
Hormone patterns in PMDD vs. healthy controls
This study compares hormone levels during the luteal phase (the time between ovulation and your period) in people with PMDD versus those without symptoms. It involves collecting a blood sample mid-luteal phase to better understand what causes PMDD.
Lancaster, LancashireAges 18–45 - NCT07672717RecruitingPhase 1
Cabotegravir and hormone interaction study for HIV prevention
This study tests how a long-acting injectable HIV prevention drug (cabotegravir) works in people who also use hormone therapy (like birth control or gender-affirming hormones). The goal is to see if the hormones affect how well the drug prevents HIV. If you are HIV-negative, use hormones, and meet other health criteria, you may be able to join.
Baltimore, MarylandAges 19 years+ - NCT07671092RecruitingEarly Phase 1
Imaging study for advanced cancers
This trial is testing a new imaging method to see if it can help find cancer that has spread in people with certain advanced cancers like bladder cancer, breast cancer, or lung cancer.
St Leonards, New South WalesAges 18 years+ - NCT06679491Recruiting
How your menstrual cycle affects strength training
This study looks at how resistance training timed to your menstrual cycle affects muscle performance in women who have a natural cycle or take the pill.
Le Tampon, FranceAges 18 years+ - NCT07661927RecruitingPhase 2
Skipping hormone therapy for low-risk breast cancer
This trial tests whether women with very low-risk, early-stage breast cancer can safely skip hormone therapy after surgery. It is designed for women who are 60 or older and whose cancer shows no spread to lymph nodes and has favorable biology.
AngersAges 60 years+ - NCT07650682Recruiting
Blood Sugar and Hormone Patterns in Type 2 Diabetes
This study uses math models to understand how your blood sugar and hormones respond to food and insulin. You'll eat study foods and provide blood samples so researchers can better predict how your body handles diabetes.
Chicago, IllinoisAges 18–65 - NCT07647016RecruitingPhase 2
New Drug Combination for Advanced Hormone-Receptor-Positive Breast Cancer
This study tests two drugs together—trastuzumab deruxtecan and ivonescimab—for advanced breast cancer that is hormone-receptor-positive but HER2-negative or HER2-low. These drugs work by targeting cancer cells in different ways and may help slow or shrink tumors in patients whose cancer has progressed after earlier treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07650240RecruitingPhase 2
PSMA Therapy and Hormone Treatment for Early-Stage Prostate Cancer Spread
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
Rochester, MinnesotaAges 18 years+ - NCT07641075Recruiting
High-Dose Vitamin D Effects in Experienced Athletes
This study tests whether high-dose vitamin D supplements improve athletic performance, brain function, and body composition in experienced athletes. Researchers will measure hormones, muscle strength, thinking ability, and muscle mass over time.
Katowice, Mikołowska 72aAges 17–60 - NCT07620067Recruiting
GnRH Hormone for IVF Embryo Support
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
JerusalemAges 18–45 - NCT07613151Recruiting
Lobular breast cancer with low hormone receptors
This study looks at a rare type of breast cancer called invasive lobular carcinoma that has low or no hormone receptors. The goal is to learn more about how this cancer behaves, which may help improve future treatments.
PadovaAges 18 years+ - NCT07612891RecruitingPhase 1/Phase 2
Testing INV-6452 for advanced breast cancer and solid tumors
This study tests a new drug called INV-6452 to see if it is safe and can help control advanced cancers that have grown despite prior treatment. The drug targets specific cancer cell weaknesses, particularly in hormone-sensitive breast cancers without HER2 mutations.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07610720RecruitingPhase 2
Dalpiciclib With Anti-HER2 and Hormone Therapy for Advanced Breast Cancer
This trial tests a combination of three drugs—dalpiciclib (a new cell-cycle inhibitor), anti-HER2 therapy, and hormone therapy—for advanced breast cancer that is positive for both hormone receptors and HER2 protein. The goal is to help patients whose cancer has responded to initial treatment stay in remission longer.
Guangdong, GUANGZHOUAges 18–75 - NCT07604272RecruitingPhase 1
Sex Hormones to Shrink Inguinal Hernias in Older Men
This study tests whether hormone treatment can help shrink inguinal hernias (bulges in the groin) without surgery. Men 50 and older with a confirmed hernia may qualify to see if this approach works and is safe.
Chicago, IllinoisAges 50 years+ - NCT06357442Recruiting
Comparing progesterone methods for young people on estrogen therapy
This study compares two ways to give progesterone to young people on estrogen replacement therapy to see how they affect the lining of the uterus. It will help find which approach may be safer and more effective for your health.
Aurora, ColoradoAges 12–25 - NCT06661603Recruiting
Yoga and meditation for medical students' health
This study looks at how doing yoga and meditation might affect stress hormones, immune markers, and health in medical students. If you are a medical student at the University of Pecs, you may be able to join and learn how these practices can help your well-being.
Pécs, PécsAges 18–40 - NCT07578116RecruitingPhase 3
Adding surgery and radiation for her2-positive breast cancer with a few spread spots
This trial tests whether adding surgery and radiation to the usual HER2-targeted treatment helps people with breast cancer that has spread to a few spots. You must have HER2-positive cancer that is newly spread, and you must be able to receive radiation to all tumor sites.
Jonesboro, ArkansasAges 18 years+ - NCT07580209Recruiting
Brain hormone and metabolism study in anorexia nervosa
This research study examines how the brain regulates hormones and metabolism in people with long-standing anorexia nervosa. By comparing brain samples from people with the condition to healthy volunteers, researchers hope to understand the biological changes that occur and develop better treatments.
ZurichAges 18–45 - NCT07568574Enrolling by invitation
Medical Study of Performance-Enhancing Substances in Elite Athletes
This study looks at how medically supervised performance-enhancing substances affect elite athletes' health and quality of life. Participants must be retired from professional sports and willing to undergo careful medical monitoring throughout the trial.
Abu DhabiAges 18 years+ - NCT05335317Recruiting
Low-intensity laser for vaginal thinning and irritation
This trial studies whether a low-intensity nanosecond laser can improve vaginal atrophy (vaginal thinning) and related symptoms. It may help reduce discomfort for people who fit the study conditions and can complete the required visits and procedures.
Nizhny NovgorodAges 40–75 - NCT07560748Recruiting
Prostate Cancer Registry and Research Study
This study collects medical information and tissue samples from men with prostate cancer to better understand the disease and improve future treatment. You'll provide consent and allow researchers to use your health data and biopsy samples for studies.
NijmegenAges 18 years+ - NCT06734533Recruiting
Anlotinib combo for HR+ breast cancer that has spread
This trial tests a combination treatment including anlotinib for women with hormone receptor-positive breast cancer that has spread to other parts of the body and has stopped responding to standard therapies. It is for those who have already tried a CDK4/6 inhibitor and endocrine therapy.
Changsha, HunanAges 18–75 - NCT07553234Recruiting
Gut Health and Side Effects from Breast Cancer Hormone Treatment
This study looks at how the bacteria in your digestive system may affect side effects from abemaciclib, a hormone-based breast cancer drug. By collecting stool samples, researchers hope to understand which patients might experience fewer problems and how to better manage treatment.
Chicago, IllinoisAges 18 years+ - NCT07539038Recruiting
Exercise Program for Early-Stage Hormone-Positive Breast Cancer
This study tests whether a structured exercise program helps women with early-stage hormone-positive breast cancer who are taking endocrine therapy (hormone-blocking medications). The goal is to see if physical activity improves outcomes and quality of life during treatment.
Aviano, PordenoneAges 18 years+
Hear when a new Hormones trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hormones?
- Yes. Clin2 currently lists 423 recruiting hormones studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hormones trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hormones trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.